PT3411389T - Novas proteases estreptocócicas - Google Patents

Novas proteases estreptocócicas

Info

Publication number
PT3411389T
PT3411389T PT177039583T PT17703958T PT3411389T PT 3411389 T PT3411389 T PT 3411389T PT 177039583 T PT177039583 T PT 177039583T PT 17703958 T PT17703958 T PT 17703958T PT 3411389 T PT3411389 T PT 3411389T
Authority
PT
Portugal
Prior art keywords
proteases
new
new streptococcal
streptococcal proteases
streptococcal
Prior art date
Application number
PT177039583T
Other languages
English (en)
Original Assignee
Genovis Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=57995190&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT3411389(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genovis Ab filed Critical Genovis Ab
Publication of PT3411389T publication Critical patent/PT3411389T/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6402—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
    • C12N9/6405—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals not being snakes
    • C12N9/641—Cysteine endopeptidases (3.4.22)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PT177039583T 2016-02-04 2017-02-03 Novas proteases estreptocócicas PT3411389T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE1630021 2016-02-04

Publications (1)

Publication Number Publication Date
PT3411389T true PT3411389T (pt) 2021-06-28

Family

ID=57995190

Family Applications (1)

Application Number Title Priority Date Filing Date
PT177039583T PT3411389T (pt) 2016-02-04 2017-02-03 Novas proteases estreptocócicas

Country Status (12)

Country Link
EP (1) EP3411389B1 (pt)
JP (2) JP7123801B2 (pt)
KR (1) KR20180124857A (pt)
CN (1) CN109311951B (pt)
AU (1) AU2017214441B2 (pt)
CA (1) CA3013527C (pt)
DK (1) DK3411389T3 (pt)
ES (1) ES2877754T3 (pt)
PL (1) PL3411389T3 (pt)
PT (1) PT3411389T (pt)
SG (1) SG11201806639VA (pt)
WO (1) WO2017134274A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2861600T3 (es) 2014-04-04 2021-10-06 Mayo Found Medical Education & Res Isotipaje de inmunoglobulinas usando masa molecular precisa
JP6968058B2 (ja) 2015-09-24 2021-11-17 メイヨ・ファウンデーション・フォー・メディカル・エデュケーション・アンド・リサーチ 質量分析法による免疫グロブリン遊離軽鎖の同定
AU2017325022B2 (en) 2016-09-07 2022-10-13 Mayo Foundation For Medical Education And Research Identification and monitoring of cleaved immunoglobulins by molecular mass
CA3063828A1 (en) 2017-05-26 2018-11-29 Genovis Ab Enzymes for glycan analysis
US20210228738A1 (en) 2017-07-17 2021-07-29 INSERM (Institut National de la Santé et de la Recherche Médicale) Compositions and methods for increasing or enhancing transduction of gene therapy vectors and for removing or reducing immunoglobulins
WO2019055634A1 (en) 2017-09-13 2019-03-21 Mayo Foundation For Medical Education And Research IDENTIFICATION AND MONITORING OF A MACROPHAGE APOPTOSIS INHIBITOR
KR20200100055A (ko) * 2017-12-15 2020-08-25 인터벳 인터내셔널 비.브이. 연쇄상구균에 대한 보호를 위한 백신
JP2022550435A (ja) 2019-10-04 2022-12-01 ウルトラジェニックス ファーマシューティカル インコーポレイテッド 組換えａａｖの改善された治療的使用のための方法
MX2022009982A (es) 2020-02-14 2022-09-12 Ultragenyx Pharmaceutical Inc Terapia genica para el tratamiento de transtorno por deficiencia de cdkl5.
EP4169934A1 (en) * 2020-06-18 2023-04-26 Shanghai Bao Pharmaceuticals Co., Ltd. Mutant of immunoglobulin degrading enzyme idee
EP4079848A1 (en) 2021-04-22 2022-10-26 Genovis Ab Immunoglobulin cleaving enzyme
WO2022266044A1 (en) * 2021-06-15 2022-12-22 The University Of North Carolina At Chapel Hill Methods and compositions for depleting antibodies
WO2023019168A1 (en) 2021-08-11 2023-02-16 Ultragenyx Pharmaceutical Inc. Compositions and methods for treating a muscular dystrophy
WO2023088988A1 (en) * 2021-11-18 2023-05-25 Intervet International B.V. A method to produce a vaccine against streptococcus suis and the said vaccine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2824074A1 (fr) * 2001-04-26 2002-10-31 Pasteur Institut Sequence du genome streptococcus agalactiae, application au developpement de vaccins, d'outils de diagnostic, et a l'identification de cibles therapeutiques
GB0130228D0 (en) * 2001-12-18 2002-02-06 Hansa Medica Ab Protein
JP2008525033A (ja) 2004-12-22 2008-07-17 ノバルティス ヴァクシンズ アンド ダイアグノスティクス， インコーポレイテッド Ｂ群連鎖球菌
EP1901773B1 (en) * 2005-06-09 2012-03-07 Hansa Medical AB Use of the ides proteinase (from s. pyogenes) for treating autoimmune diseases and graft rejection
DK2190984T3 (da) 2007-09-14 2013-12-02 Genovis Ab Fremgangsmåder og kits til oprensning og påvisning af glycosyleret IgG
GB201115841D0 (en) * 2011-09-13 2011-10-26 Genovis Ab Protein and method
GB201316744D0 (en) * 2013-09-20 2013-11-06 Genovis Ab Method

Also Published As

Publication number Publication date
AU2017214441A1 (en) 2018-08-16
SG11201806639VA (en) 2018-09-27
CN109311951B (zh) 2022-10-11
PL3411389T3 (pl) 2021-10-25
ES2877754T3 (es) 2021-11-17
JP2022115853A (ja) 2022-08-09
US20190345533A1 (en) 2019-11-14
DK3411389T3 (da) 2021-06-21
CN109311951A (zh) 2019-02-05
WO2017134274A1 (en) 2017-08-10
KR20180124857A (ko) 2018-11-21
CA3013527C (en) 2023-09-05
JP7123801B2 (ja) 2022-08-23
CA3013527A1 (en) 2017-08-10
EP3411389A1 (en) 2018-12-12
JP2019506866A (ja) 2019-03-14
EP3411389B1 (en) 2021-03-24
AU2017214441B2 (en) 2021-08-19

Similar Documents

Publication Publication Date Title
PL3411389T3 (pl) Nowe proteazy streptokokowe
IL253939B (en) cysteine protease
IL253938A0 (en) cysteine protease
AU201616678S (en) Cylindres
GB2550864B (en) Well
GB201621111D0 (en) Neurotoxins
SG10202007262PA (en) Copanlisib biomarkers
SG10202007322PA (en) Copanlisib biomarkers
GB201614455D0 (en) Biomarkers
AU201617244S (en) Case
PL3458583T3 (pl) Proteazy o polepszonej skuteczności
PL3469691T3 (pl) Konfiguracja szyku halbacha
PL3420078T3 (pl) Warianty beta-laktamazy
GB201513444D0 (en) Peptoid
PL3106268T3 (pl) Walizka narzędziowa
GB201715589D0 (en) Protease inhibitors
GB201618005D0 (en) Keys
GB201621467D0 (en) Modified bulgeomers
GB201615101D0 (en) Keys
GB201611096D0 (en) Face up
GB201616374D0 (en) Modified bulgeomers
GB201614858D0 (en) Modified Bulgeomers
AP2016001138S (en) Chisa kooka
GB201611746D0 (en) Snagg free
AU2016187V (en) DamprostGL Westringia dampieri